Kyle D. Monroe

4 Patents

• US119446192024

  Phenylalanine Small Organic Compounds to Directly Modulate PCSK9 Protein Activity

  SRX Cardio, LLC

  0 cites
• US119457822024

  Composition and Methods of Use of Tetrahydroisoquinoline Small Molecules to Bind and Modulate PCSK9 Protein Activity

  SRX Cardio, LLC

  0 cites
• US119256372024

  Phenylpiperazine Proprotein Convertase Subtilisin/kexin Type 9 (PCSK9) Modulators and Their Use

  SRX Cardio, LLC

  0 cites
• US117717102023

  Method to Treat Lipid Dysregulation by Modulation of Proprotein Convertase Subtilisin/kexin Type 9 (PCSK9) Protein Activity with Small Molecule Ligands

  SRX CARDIO, LLC

  0 cites